Testing Options

Our molecular diagnostic method for UTIs utilizes semi-quantitative qPCR, which targets specific pathogens and resistance genes. This includes testing for clinically relevant pathogens, multiple antibiotic resistance genes. For specimens with > 10,000 cells/mL of bacterial pathogen, the Mokan phenotypic molecular susceptibility testing is completed for a panel of pathogen specific antibiotics. 

Results are reported to healthcare providers within ~8 hours of receiving the specimen for positive or negative results, with full phenotypic antibiotic susceptibility testing results available within ~24 hours for positive cases.

Pathogens: 

• Acinetobacter baumanii
• Candida albicans
• Candida glabrata
• Candida parapsilosis
• Citrobacter freundii
• Enterobacter aerogenes
• Enterobacter cloacae
• Enterococcus faecalis
• Enterococcus faecium
• Escherichia coli
• Gardnerella vaginalis
• Klebsiella oxytoca
• Klebsiella pneumoniae
• Morganella morganii
• Mycoplasma hominis
• Proteus mirablis
• Proteus vulgaris
• Providencia stuartii
• Pseudomonas aeruginosa
• Serratia marcescens
• Staphylococcus aureus
• Staphylococcus saprophyticus
• Streptococcus agalactiae (Group B Strep)
• Ureaplasma urealyticum

Antibiotic Resistance Genes:

• Ampicillin Resistance Marker: ampC
• Carbapenem Resistance Markers: Oxa-48, KPC, VIM/IMP-7/NDM
• ESBL Resistance Markers: SHV, TEM, CTX-M Group 1/2
• Methicillin Resistance Markers: mecA, femA
• Quinolone and Fluoroquinolone Resistance Markers: QnrA/QnrB/QnrS
• Vancomycin Resistance Markers: VanA1/vanA2, VanB 

While genetic mutations may not always be expressed, they can become active under certain cellular conditions and emphasizes the importance of both genotypic and phenotypic antibiotic susceptibility testing. Our UTI test goes beyond just testing for antibiotic resistant genes. 

Positive samples are also run on our proprietary molecular platform that determines molecular phenotypic antibiotic susceptibility. Results are provided to physicians in less than ~24 hours.

We test for the same 23 uropathogens in our UTI panel for this specimen type using rapid and accurate PCR technology. Antibiotic resistance genes are evaluated. For specimens with > 10,000 cells/mL of bacteria detected, our proprietary molecular antibiotic susceptibility testing is completed. 

Results are reported to healthcare providers within ~8 hours of receiving the specimen at the laboratory.

Mokan provides semen collection kits for at home use. Patients are typically provided with the kit in your clinic. The specimen is collected at home by the patient and shipped directly to our laboratory via a pre-paid UPS shipping envelope.

We test for 11 of the most common pathogens associated with sepsis and UTI after transrectal prostate biopsy Pathogen detection is completed utilizing our custom PCR platform. Molecular phenotypic antibiotic susceptibility testing is then completed to help guide healthcare providers on patient specific pre-biopsy antibiotic prophylaxis. 

Final antibiotic susceptibility results are reported in ~24 hours of receiving the specimen at the laboratory. 

Pathogens:

• Acinetobacter baumannii
• Enterobacter cloacae
• Enterococcus faecalis
• Escherichia coli
• Klebsiella aerogenes
• Klebsiella pneumoniae
• Morganella morganii
• Proteus mirabilis
• Proteus vulgaris
• Pseudomonas aeruginosa
• Staphylococcus aureus

Antibiotic Resistance Genes:

• ESBL Resistance Markers: SHV, TEM, CTX-M Group 1/2
• Quinolone and Fluoroquinolone Resistance Marker: QnrA/QnrB

We test for 28 of the most common pathogens associated with vaginitis. This includes protozoans, bacterial, fungal, sexually transmitted infection, lactobacillus, and other organisms. Rapid detection is completed utilizing our custom PCR platform. 

Results are reported to healthcare providers within ~6 hours of receiving the specimen at the laboratory and includes antibiotic recommendations on the report for quick reference.

Lactobacillus Pathogens:

Lactobacillus crispatus

Lactobacillus gasseri

Lactobacillus iners

Lactobacillus jensenii

Other Vaginitis Pathogens:

Atopium vaginae

Bacterial Vaginosis (BVAB2)

Mobiluncus curtisii

Mobiluncus mulieris

Megaspherae 1

Megaspherae 2

Prevotella bivia

Fungal Pathogens:

Candida albicans

Candida glabrata

Candida krusei

Candida parapsilosis

Candida tropicalis

STI Pathogens:

Chlamydia trachomatis

Gardnerella vaginalis

Mycoplasma hominis

Mycoplasma genitalium

Neisseria gonorrhoea

Trichomonas vaginalis

Ureaplasma urealyticum

Ureaplasma parvum

Bacterial Pathogens:

E. coli

Enterococcus faecalis

Streptococcus agalactiae

Staphylococcus aureus

We test for the 23 uropathogens in our UTI panel along with antibiotic resistance genes for kidney stone testing. 

Traditional stone cultures take 3-5 days to result for bacterial species and weeks to result for fungal pathogens. Our molecular pathogen identification results for kidney stones are reported to healthcare providers within ~8 hours of receiving the specimen at the laboratory, expediting care for patients. 

We test for 7 common pathogens associated with sexually transmitted infections or non-gonococcal urethritis using PCR technology. This allows for rapid detection and timely results for our healthcare providers and patients.

• Neisseria gonorrhoeae
• Chlamydia trachomatis
• Trichomonas vaginalis
• Gardnerella vaginalis
• Mycoplasma genitalium
• Mycoplasma hominis 
• Ureaplasma urealyticum 

Our laboratory utilizes PCR technology to identify common  pathogens causing respiratory illness. Specimens are ordered by a healthcare provider, collected at your facility or office, and then shipped overnight to our lab. Our limited viral respiratory pathogen panel tests both boast high sensitivity and specificity.

- Limited Viral Respiratory Panel (LVRP): 

• Influenza A
• Influenza B
• RSV

PCR viral testing is more sensitive than rapid viral detection kits, resulting in fewer false negatives. Rapid tests typically have a lower limit of detection of 125-140 genome equivalents/mL, while PCR technology can detect infection at lower viral loads (40 genome equivalents/mL) by requiring less viral genetic material.

We offer fast turnaround time, with results for our respiratory pathogen tests available on the day of specimen arrival at the lab. Our reports include CT mean values, which can aid in evaluating viral load.